Marc Ullman was cited in the NutraIngredients-USA article, “FDA takes aim at claims for infant food allergy prevention.”

Two companies have received warning letters from the FDA for claiming that their products can prevent young children from developing certain food allergies.

Marc states that the companies can petition the FDA for a broadening of the

Marc Ullman spoke to Natural Products Insider for the story, “Execs of once-thriving supplements brand USPlabs sentenced to prison.”

USPlabs’ product, OxyElitePro, was implicated in dozens of cases of liver injuries. In 2015, the company and its contract manufacturer were indicted along with USPlabs’ executives who defended the charges for years.

Marc noted that FDA-regulated

Jeff Kaiser spoke to Healthcare Risk Management regarding a West Virginia hospital’s $50 million settlement to address a whistle-blower complaint that the hospital, over 13 years, systematically violated the Stark Law and Anti-Kickback Statute by paying improper compensation to referring physicians based on their patient referrals.

Jeff notes, “a hospital may not pay excessive compensation

On September 30, Marc Ullman spoke at the Natural Products Insider webinar “Hemp Evolution: Surviving the imminent regulatory shockwave.”

The presentation discussed mitigating legal risks and thriving in the multi-billion dollar hemp phytocannabinoid market.

The video is still available to view. Click here to register and watch.

On October 13, Jeff Kaiser will be speaking at the Life Sciences 2020: Navigating Legal Challenges in Drug and Device Industries.

Jeff will be speaking on the topic of, “Enforcement Trends impacting the Drug and Device Industries” focusing on the following areas:

• False Claims Act
• Anti-Kickback Statute
• Off-label promotion
• Individual liability

Click here

On October 7, 2020, Marc Ullman will be a panelist at the webinar “Your COVID Communications Could be Illegal: Here’s How to Avoid FDA & FTC Trouble.”

The event is hosted by the American Association of Naturopathic Physicians and is free to attend.

In this program, you’ll learn about:

• The laws governing permissible language

Six attorneys from Rivkin Radler will be speakers at USLAW Network’s virtual retreat, which takes place September 30 through October 9. The retreat is intended for general counsel, in-house counsel, heads and managers of claims and risk, C-suite executives, and other legal decision makers.

The program will cover issues beyond COVID-19, projecting what the future

Brian Bank, Michelle Bholan and Geoffrey Kaiser secured pre-answer dismissal of various False Claims Act claims brought against three New York nephrologists by a relator, also a nephrologist.

The action, which the relator brought on behalf of the United States of America under the False Claims Act’s qui tam provisions, alleged two theories against the

Jeff Kaiser was quoted in Part B News, “Do Stark waivers cover your rent break? Only if the break meets ‘COVID-19 purposes.”

The article discusses the new Stark Law waivers issued due to the COVID-19 pandemic. One waiver in particular covers rental arrangements that are under fair market value (FMV) which are normally forbidden under

On August 11, John Queenan will be a panelist at Albany Law’s Virtual-Recent Graduate CLE.

He will be speaking on the topic of “Starting Strong: Case Considerations/Initial To-Dos/Early Case Assessment and Action.”

Click here to register. A zoom link will be sent over email.